# Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

> **NCT03983551** · PHASE4 · COMPLETED · sponsor: **Changhua Christian Hospital** · enrollment: 101 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Proteinuria

## Interventions

- **DRUG:** Dipeptidyl Peptidase 4 Inhibitor
- **DRUG:** Sulfonylurea

## Key facts

- **NCT ID:** NCT03983551
- **Lead sponsor:** Changhua Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2018-02-10
- **Final completion:** 2018-02-28
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03983551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03983551, "Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03983551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*